Loading chat...
FL S1688
Bill
AI Summary
- Amends Florida Statutes section 893.03 to exclude cannabis from the Schedule I controlled substances list when it is contained within a pharmaceutical product approved by the U.S. Food and Drug Administration
- Cannabis would remain classified as a Schedule I hallucinogenic substance in all other contexts outside of FDA-approved pharmaceutical products
- Mirrors existing exceptions already in Florida law for Salvia divinorum, Salvinorin A, synthetic cannabinoids, substituted cathinones, and other substance categories that similarly exempt FDA-approved pharmaceutical products
- Sponsored by Senator Gruters during the 2022 Florida legislative session
- Takes effect immediately upon becoming law
Legislative Description
Pharmaceutical Products Containing Cannabis
Last Action
Died in Regulated Industries
3/14/2022
Full Bill Text
No bill text available